Forward from the CEO

ChrisI would like to welcome you to OSOD where we are setting the standard for the delivery of ocular services.

Our university-based leaders in biomedical research study the full range of ophthalmic diseases in a wide variety of species within every element of the visual system. Our dedicated veterinary and physician ophthalmologists and pathologists as well as vision scientists conduct research aimed at identifying the physiological, biochemical, and molecular mechanisms contributing to the onset and progression of glaucoma, age-related macular degeneration, cataract, wound-healing, and diverse ocular diseases affecting all components of the visual system. 

We work closely with Covance Laboratories, Inc., a world-renowned leader in comprehensive drug development, to assist in the identification and development of lead ocular therapeutic compounds and ophthalmic devices and in the evaluation of "off target" ocular toxicities. Over the past decade, we have participated in the execution of over 400 industry studies in association with Covance, Inc.  In addition, we have conducted a number of university-based studies and have lent our expertise to "in house" industry projects.  Together, we are committed to improving the lives of patients with ocular diseases and disorders. 

We invite you to explore our site, review our research and development activities, and contact us to find out how we can best use our expertise to meet your needs in discovery, establishing proof of concept, accelerating drug/device development, and assessment of ocular toxicities.

Sincerely,

Christopher J. Murphy, DVM, PhD, Diplomate ACVO